Man Alive Inc
Analysis
Man Alive Inc is a registered charity in United States, based in Baltimore, MD. It received its IRS tax-exemption ruling in May 2024, 2 years ago. Its declared purposes cover mental health and crisis intervention, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Man Alive Inc reported income of $4.2m and spending of $3.2m, leaving 24% of income unspent that year. Across the 3 years on record, from June 2019 to June 2023, income grew from $3.3m to $4.2m (+25%), an average of +12% a year. The sharpest change came in the year to June 2022, when income rose by 18%. Over the whole period it spent 82% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Man Alive Inc sits at the 78th percentile: it is larger than about 78% of them. Against every charity in United States with reported income it ranks in the 91st percentile, and in the 90th percentile within MD. Charities of a similar size with the same main cause include Morselife Hospice Institute Inc ($4.2m), Aneta Parkview Health Center ($4.2m) and Share Cancer Support Inc ($4.2m).
On its Form 990 for the period ending June 2023, revenue came from program service revenue 100% of the total. Compensation of current officers, directors and key employees was $224k (7.0% of expenses). Other salaries and wages came to $1.5m. At year end it held assets of $3.8m against liabilities of $294k, net assets of $3.5m. It reported 31 employees.
Income and spending
Where the income comes from
- Program services 100%
- Other 0.0%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Morselife Hospice Institute Inc | West Palm BCH | $4.2m |
| Aneta Parkview Health Center | Aneta | $4.2m |
| Share Cancer Support Inc | New York | $4.2m |
| Association of Women in Rheumatology | Fayetteville | $4.2m |